PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in PolyPid Ltd. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −3 vs. Q2 2021
- Shares held
- 1.53M
- −112.7K (−6.9%) vs. Q2 2021
- Total value
- $11.9M
- −$2.97M (−20.0%) vs. Q2 2021
- New holders
- 0
- 7 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PYPD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $16.7M |
| Q1 2026 | 19 | $13.7M |
| Q4 2025 | 19 | $13.0M |
| Q3 2025 | 16 | $9.45M |
| Q2 2025 | 15 | $10.2M |
| Q1 2025 | 13 | $6.90M |
| Q4 2024 | 14 | $7.50M |
| Q3 2024 | 12 | $6.64M |
| Q2 2024 | 9 | $5.18M |
| Q1 2024 | 8 | $5.13M |
| Q4 2023 | 5 | $79.6K |
| Q3 2023 | 4 | $93.2K |
| Q2 2023 | 14 | $155.2K |
| Q1 2023 | 11 | $147.8K |
| Q4 2022 | 13 | $265.3K |
| Q3 2022 | 18 | $566.0K |
| Q2 2022 | 27 | $4.95M |
| Q1 2022 | 27 | $6.10M |
| Q4 2021 | 27 | $8.71M |
| Q3 2021 | 19 | $11.9M |
| Q2 2021 | 22 | $14.9M |
| Q1 2021 | 20 | $14.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding PolyPid Ltd.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 2,053 | $16.0K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,115 | $16.0K | 0.00% | +500+31.0% | Added |
| Morgan Stanley | 3,000 | $24.0K | 0.00% | −494−14.1% | Reduced |
| BlackRock Inc. | 3,091 | $24.0K | 0.00% | 00.0% | Unchanged |
| 1623 Capital LLC | 11,627 | $90.0K | 0.04% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 11,719 | $91.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,545 | $97.0K | 0.00% | +1,364+12.2% | Added |
| Raymond James & Associates | 16,351 | $127.0K | 0.00% | +406+2.5% | Added |
| Federated Hermes, Inc. | 18,194 | $142.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 20,830 | $162.0K | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 21,088 | $164.0K | 0.00% | −3,031−12.6% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 24,361 | $190.0K | 0.00% | +4,545+22.9% | Added |
| Meitav Dash Investments Ltd | 31,500 | $246.0K | 0.00% | +17,000+117.2% | Added |
| Alliancebernstein L.P. | 100,000 | $778.0K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 111,617 | $868.0K | 0.00% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 183,230 | $1.43M | 0.83% | +28,664+18.5% | Added |
| UBS Group AG | 204,555 | $1.59M | 0.00% | +50,395+32.7% | Added |
| Moore Capital Management, LP | 279,942 | $2.18M | 0.04% | −2,035−0.7% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 471,414 | $3.67M | 0.01% | −133,968−22.1% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −56,530−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −19,189−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −327−100.0% | Sold out |